Stockreport

Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies

Mustang Bio, Inc.  (MBIO) 
Last mustang bio, inc. earnings: 11/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: mustangbio.com/investor-relations
PDF Entered license agreement with Fred Hutchinson Cancer Research Center for CD20-directed CAR T Initiation of Phase 1/2 investigator-initiated trial in B-cell non-Hodgkin [Read more]